GeneOne Life Science, Inc.

011000 KRX Pharmaceuticals Pharmaceuticals
KOSPI

Shareholding pattern

As reported to FSS/DART, 2025-12-31.

Largest shareholder group8.92%
Minority shareholders85.37%
Top 10 holders8.92%
Total shareholders107,929

Who owns the company

Share of shares outstanding
Minority shareholders: 85.37%Largest shareholder & related parties: 8.92%Institutions & other holders: 5.71%85.4%Minority shareholders
Minority shareholders 85.37%Largest shareholder & related parties 8.92%Institutions & other holders 5.71%

How to read this: the largest shareholder group is the controlling owner and related parties — a big slice means tight control. Minority shareholders are the many small holders. The remainder is mostly institutional and foreign money, which the regulator does not itemise separately.

Ownership detail

Investor categoryHolding %Shareholders
Minority shareholders85.37%107,920
Largest shareholder & related parties8.92%
Institutions & other holders5.71%

How to read this: a high foreign or institutional share often means the stock is widely researched and more liquid; a high individual share means retail investors hold most of the company. Percentages are of voting units.

Largest shareholders

S.No.ShareholderSharesStake %
1박영근6,000,8737.03%
2조병문887,9261.04%
3EDWARDJAEHOCHUNG490,3630.57%
4채재경135,8170.16%
5박희곤64,5000.08%
6Joel N. Maslow20,7600.02%
7이혜영11,3770.01%
8정봉기5,1190.01%

Trust banks such as Master Trust and Custody Bank appear at the top of most Japanese registers: they hold shares on behalf of many underlying funds rather than owning them outright.

Educational data only. Not a recommendation to buy, sell or hold any security.